[{"id":"20220426147","sourceId":"marketwatch","sourceName":"MarketWatch","providerName":"Dow Jones","title":"Pfizer, Valneva plan to move Lyme disease vaccine candidate into Phase 3 trial","publishedDate":"2022-04-26T06:59:00-05:00"},{"id":"20220426137","sourceId":"marketwatch","sourceName":"MarketWatch","providerName":"Dow Jones","title":"China's latest COVID outbreak spooks investors, while U.S. cases and hospitalizations are rising again","publishedDate":"2022-04-26T06:44:00-05:00"},{"id":"20220426005272","sourceId":"business-wire","sourceName":"Business Wire","providerName":"Business Wire","title":"Valneva and Pfizer Report Positive Phase 2 Pediatric Data for Lyme Disease Vaccine Candidate","publishedDate":"2022-04-26T05:45:00-05:00"},{"id":"20220425170","sourceId":"marketwatch","sourceName":"MarketWatch","providerName":"Dow Jones","title":"Valneva says the EMA wants additional data about its experimental COVID-19 shot","publishedDate":"2022-04-25T07:40:00-05:00"},{"id":"20211217366","sourceId":"marketwatch","sourceName":"MarketWatch","providerName":"Dow Jones","title":"New COVID-19 booster candidates are still being developed as omicron spreads","publishedDate":"2021-12-17T08:40:00-06:00"},{"id":"20211216514","sourceId":"marketwatch","sourceName":"MarketWatch","providerName":"Dow Jones","title":"Valneva's stock is up 14% after the company shares promising data for its COVID-19 booster candidate","publishedDate":"2021-12-16T11:54:00-06:00"},{"id":"2021120666","sourceId":"marketwatch","sourceName":"MarketWatch","providerName":"Dow Jones","title":"A new study finds that most COVID-19 boosters strengthen immunity, though there is no winning shot","publishedDate":"2021-12-06T06:08:00-06:00"},{"id":"20211018118","sourceId":"marketwatch","sourceName":"MarketWatch","providerName":"Dow Jones","title":"Valneva shares spike after saying vaccine candidate outperformed AstraZeneca's","publishedDate":"2021-10-18T06:26:00-05:00"},{"id":"2021101888","sourceId":"marketwatch","sourceName":"MarketWatch","providerName":"Dow Jones","title":"Coronavirus tally: Global cases of COVID-19 top 240 million and U.S. edges toward 725,000 fatalities","publishedDate":"2021-10-18T06:04:00-05:00"},{"id":"2021101835","sourceId":"marketwatch","sourceName":"MarketWatch","providerName":"Dow Jones","title":"Valneva shares jump 30% after saying vaccine candidate outperformed AstraZeneca's","publishedDate":"2021-10-18T03:14:00-05:00"},{"id":"20211011136","sourceId":"marketwatch","sourceName":"MarketWatch","providerName":"Dow Jones","title":"Allowing people to mix COVID-19 vaccines could cut into Pfizer and Moderna's revenue next year","publishedDate":"2021-10-11T07:13:00-05:00"},{"id":"2021091474","sourceId":"marketwatch","sourceName":"MarketWatch","providerName":"Dow Jones","title":"Biden to announce new pandemic steps ahead of U.N. meeting Tuesday, as global COVID-19 case tally nears 225 million","publishedDate":"2021-09-14T06:28:00-05:00"},{"id":"20210521688","sourceId":"marketwatch","sourceName":"MarketWatch","providerName":"Dow Jones","title":"Booster dose of COVID vaccines to be given to U.K. volunteers in new trial","publishedDate":"2021-05-21T14:57:00-05:00"}]